SENSITIN FOR ERYTHROCYTIC DIAGNOSTICUM FOR DIAGNOSIS OF MALIGNANT GROWTHS AND METHOD FOR MAKING IT, ERYTHROCYTIC DIAGNOSTICUM FOR DIAGNOSIS OF MALIGNANT GROWTHS AND METHOD FOR MAKING IT AND DIAGNOSTIC TECHNIQUE FOR PRESENCE OF MALIGNANT GROWTHS WITH USING SUCH ERYTHROCYTIC DIAGNOSTICUM Russian patent published in 2012 - IPC A61K35/16 G01N33/50 G01N33/574 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, and concerns diagnosis of oncological diseases. What is developed is an erythrocytic diagnosticum containing formalised sheep erythrocytes sensitised by a mixture of fractions of low-molecular protein compounds of molecular weight 3000-15000 Da recovered from blood serum of pregnant horses on their 20-60th day of pregnancy, and reacting with proteins stimulating malignant cell proliferation. A method for producing the erythrocytic diagnosticum for diagnosing the presence of malignant growths involving sensitisation of a suspension of formalised mammal erythrocytes in a buffer solution of pH 6.4-6.6 with sensitin. The sensitin is presented by the mixture of fractions of low-molecular protein compounds of molecular weight 3000-15000 Da recovered from blood serum of pregnant horses in early pregnancy, and interacting with proteins stimulating malignant cell proliferation. A diagnostic technique for malignant growths with using the erythrocytic diagnosticum.

EFFECT: invention provides high-reliability detection of the presence of malignant diseases in the patients and instant examination of bigger population groups.

13 cl, 57 ex, 12 tbl, 4 dwg